121082-99-3

Basic information

• Product Name: 1-(3,4,5-TRIMETHOXY-PHENYL)-ETHYLAMINE
• Synonyms: 1-(3,4,5-TRIMETHOXY-PHENYL)-ETHYLAMINE;1-(3,4,5-trimethoxyphenyl)ethanamine(SALTDATA: HCl);1-(3,4,5-trimethoxyphenyl)ethanamine 1HCl;CHEMBRDG-BB 4102680;1-(3,4,5-trimethoxyphenyl)ethan-1-amine
• CAS NO: 121082-99-3
• Molecular Formula: C₁₁H₁₇NO₃
• Molecular Weight: 211.26
• Mol File: 121082-99-3.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 305.8 °C at 760 mmHg
• Flash Point: 140.7 °C
• Appearance: /
• Density: 1.063 g/cm³
• Vapor Pressure: 0.000801mmHg at 25°C
• PKA: 9.06±0.10(Predicted)
• CAS DataBase Reference: 1-(3,4,5-TRIMETHOXY-PHENYL)-ETHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,4,5-TRIMETHOXY-PHENYL)-ETHYLAMINE(121082-99-3)
• EPA Substance Registry System: 1-(3,4,5-TRIMETHOXY-PHENYL)-ETHYLAMINE(121082-99-3)

Safety Data

• Hazard Codes: C,Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 121082-99-3(Hazardous Substances Data)

Usage

General Description

1-(3,4,5-Trimethoxy-phenyl)-ethylamine, also known as TMA-6, is a chemical compound that belongs to the class of phenethylamines. It is structurally similar to the hallucinogenic drug mescaline and has been found to have hallucinogenic effects in humans. TMA-6 is known to bind to the serotonin receptor, and its effects are thought to be mediated through this interaction. It is a psychoactive substance that has been studied for its potential therapeutic effects, particularly in the treatment of depression and anxiety. However, its use is illegal in many countries and its safety and efficacy for medical use have not been established.

InChI:InChI=1/C11H17NO3/c1-7(12)8-5-9(13-2)11(15-4)10(6-8)14-3/h5-7H,12H2,1-4H3/p+1/t7-/m1/s1

Upstream product

• 1136-86-3 methyl (3,4,5-trimethoxyphenyl) ketone 

Downstream Products

• 1198079-04-7 C₂₄H₂₈N₂O₆S₂ 

Relevant articles and documents

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT